๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Safety and efficacy results of a phase II randomized, placebo-controlled, dose-ranging study of elnd005 (scyllo-inositol) in mild-to-moderate Alzheimer's disease

โœ Scribed by Salloway, Stephen; Porsteinsson, Anton; Sperling, Reisa; Keren, Ron; van Dyck, Christopher; Tariot, Pierre; Gilman, Sid; Crans, Gerald; Hernandez, Ramon; Quinn, Grainne; Bairu, Menghis; Cedarbaum, Jesse; Pastrak, Aleksandra; Abushakra, Susan


Book ID
121957681
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
105 KB
Volume
7
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES